[
    [
        {
            "time": "",
            "original_text": "预增王来了！医疗出口数据超预期，估值修复开启",
            "features": {
                "keywords": [
                    "预增",
                    "医疗",
                    "出口数据",
                    "超预期",
                    "估值修复"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "预增王来了！医疗出口数据超预期，估值修复开启",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "解析A股新晋预增王热景生物：产品顺应居家检测需求 但不乏后来者虎视眈眈",
            "features": {
                "keywords": [
                    "A股",
                    "预增王",
                    "热景生物",
                    "居家检测",
                    "竞争压力"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "解析A股新晋预增王热景生物：产品顺应居家检测需求 但不乏后来者虎视眈眈",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "国信证券-医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
            "features": {
                "keywords": [
                    "国信证券",
                    "医药行业",
                    "财报季",
                    "投资机会",
                    "药品集采"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国信证券-医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]